226 related articles for article (PubMed ID: 17923753)
1. Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and inhibition of angiogenesis.
Kim JO; Jung SS; Kim SY; Kim TY; Shin DW; Lee JH; Lee YH
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S38-46. PubMed ID: 17923753
[TBL] [Abstract][Full Text] [Related]
2. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in mice.
Wang HL; Wang YJ; Pei YJ; Bai JZ; Yin LT; Guo R; Yin GR
Parasite; 2016; 23():4. PubMed ID: 26842927
[TBL] [Abstract][Full Text] [Related]
4. Host resistance and immune deviation in pigeon cytochrome c T-cell receptor transgenic mice infected with Toxoplasma gondii.
Collazo CM; Miller C; Yap G; Hieny S; Caspar P; Schwartz RH; Sher A
Infect Immun; 2000 May; 68(5):2713-9. PubMed ID: 10768964
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity.
Chen L; He Z; Qin L; Li Q; Shi X; Zhao S; Chen L; Zhong N; Chen X
PLoS One; 2011; 6(9):e24407. PubMed ID: 21931708
[TBL] [Abstract][Full Text] [Related]
6. The opposing effect of acute and chronic Toxoplasma gondii infection on tumor development.
Song Y; Yuan H; Yang X; Yang Z; Ren Z; Qi S; He H; Zhang XX; Jiang T; Yuan ZG
Parasit Vectors; 2024 Jun; 17(1):247. PubMed ID: 38835064
[TBL] [Abstract][Full Text] [Related]
7. Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii.
Khan IA; Hakak R; Eberle K; Sayles P; Weiss LM; Urban JF
Infect Immun; 2008 Mar; 76(3):1305-13. PubMed ID: 18195022
[TBL] [Abstract][Full Text] [Related]
8. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
Yin X; Yan X; Yang Q; Cao H; Liang H
Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
[TBL] [Abstract][Full Text] [Related]
9. Strain- and Dose-Dependent Reduction of
Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
[No Abstract] [Full Text] [Related]
10. Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II.
Tan F; Hu X; Luo FJ; Pan CW; Chen XG
Vaccine; 2011 Mar; 29(15):2742-8. PubMed ID: 21315696
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
[TBL] [Abstract][Full Text] [Related]
12. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice.
Johnson LL; Sayles PC
Infect Immun; 2002 Jan; 70(1):185-91. PubMed ID: 11748181
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.
Chen J; Huang SY; Li ZY; Yuan ZG; Zhou DH; Petersen E; Zhang NZ; Zhu XQ
Vaccine; 2013 Mar; 31(13):1734-9. PubMed ID: 23370151
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.
Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ
Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875
[TBL] [Abstract][Full Text] [Related]
15. Secretory Microneme Proteins Induce T-Cell Recall Responses in Mice Chronically Infected with Toxoplasma gondii.
Saraav I; Wang Q; Brown KM; Sibley LD
mSphere; 2019 Feb; 4(1):. PubMed ID: 30814319
[TBL] [Abstract][Full Text] [Related]
16. SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection.
Seng S; Makala LH; Yokoyama M; Lim C; Choi YH; Suzuki N; Toyoda Y; Nagasawa H
Pathobiology; 2004; 71(3):144-51. PubMed ID: 15051927
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.
Gigley JP; Fox BA; Bzik DJ
J Immunol; 2009 Jan; 182(2):1069-78. PubMed ID: 19124750
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii.
Tato CM; Villarino A; Caamaño JH; Boothby M; Hunter CA
J Immunol; 2003 Mar; 170(6):3139-46. PubMed ID: 12626571
[TBL] [Abstract][Full Text] [Related]
19. Protective Toxoplasma gondii-specific T-cell responses require T-cell-specific expression of protein kinase C-theta.
Nishanth G; Sakowicz-Burkiewicz M; Händel U; Kliche S; Wang X; Naumann M; Deckert M; Schlüter D
Infect Immun; 2010 Aug; 78(8):3454-64. PubMed ID: 20498263
[TBL] [Abstract][Full Text] [Related]
20. Previous Infection with Plasmodium berghei Confers Resistance to Toxoplasma gondii Infection in Mice.
Lee DH; Chu KB; Kang HJ; Lee SH; Quan FS
Korean J Parasitol; 2019 Apr; 57(2):93-99. PubMed ID: 31104401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
